IndraLab

Statements

BLNK activates OTUD6A. 1 / 1

| 1

reach

"Our results confirmed the synergistic effect of ATR/Chk1 inhibitors and gemcitabine in OTUD6A-overexpressing BCa cells, suggesting the possible beneficial effects of targeting ATR/Chk1 in cancers with high expression of OTUD6A and CDC6."

38685067

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

BLNK activates OTUD6A. 1 / 1

INDRA sources:

Databases

Reading